home / stock / asnd / asnd message board
Subject | By | Source | When |
---|---|---|---|
Short today at 85.34 | MiamiGent | investorshub | 05/01/2023 8:42:43 PM |
Ascendis Pharma: FDA Approves Skytrofa to Treat Pediatric | crudeoil24 | investorshub | 08/25/2021 9:19:58 PM |
ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, | crudeoil24 | investorshub | 08/25/2021 9:17:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Ascendis Pharma (NASDAQ:ASND) has outperformed the market over the past 10 years by 41.19% on an annualized basis producing an average annual retur...
Tuesday, Ascendis Pharma A/S (NASDAQ:ASND) announced that the FDA extended the review date for TransCon PTH (palopegteriparatide) for adu...
- Prescription Drug User Fee Act (PDUFA) goal date extended by three months for further review of submission to August 14, 2024 COPENHAGEN, Denmark, May 14, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food and Drug Administration (FDA) n...